Axonics, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-11-15: Reporting owner Woock John; Form 4; Security Stock Options (Right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-11-15: Reporting owner Woock John; Form 4; Security Stock Options (Right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-11-15: Reporting owner snyderman nancy lynn MD; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-11-15: Reporting owner snyderman nancy lynn MD; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | Woock John Officer (EVP, Chief Mktg/Strtgy Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,555 0 owned after | $56.81 | 2024-11-15 | |
| 2024-11-15 | Woock John Officer (EVP, Chief Mktg/Strtgy Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,581 0 owned after | $45.18 | 2024-11-15 | |
| 2024-11-15 | snyderman nancy lynn MD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,167 0 owned after | $36.90 | 2024-11-15 | |
| 2024-11-15 | snyderman nancy lynn MD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $49.96 | 2024-11-15 | |
| 2024-11-15 | Sama Rinda Officer (Chief Operating Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,019 0 owned after | $56.81 | 2024-11-15 | |
| 2024-11-15 | Sama Rinda Officer (Chief Operating Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,962 0 owned after | $45.18 | 2024-11-15 | |
| 2024-11-15 | Sama Rinda Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,294 0 owned after | $69.37 | 2024-11-15 | |
| 2024-11-15 | Noblett Karen Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,963 0 owned after | $56.81 | 2024-11-15 | |
| 2024-11-15 | Noblett Karen Officer (Chief Medical Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,348 0 owned after | $45.18 | 2024-11-15 | |
| 2024-11-15 | Noblett Karen Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,998 0 owned after | $69.37 | 2024-11-15 | |
| 2024-11-15 | McNamara Robert Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $36.90 | 2024-11-15 | |
| 2024-11-15 | McNamara Robert Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,333 0 owned after | $33.85 | 2024-11-15 | |
| 2024-11-15 | McNamara Robert Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $56.20 | 2024-11-15 | |
| 2024-11-15 | Lopez Esteban Director | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $11.30 | 2024-11-15 | |
| 2024-11-15 | Ford Alfred J Jr Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,655 0 owned after | $45.18 | 2024-11-15 | |
| 2024-11-15 | Demski David M Director | 4 | Stock Options (Right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $19.30 | 2024-11-15 | |
| 2024-11-15 | COHEN RAYMOND W Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −196,451 0 owned after | $56.81 | 2024-11-15 | |
| 2024-11-15 | COHEN RAYMOND W Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −106,776 0 owned after | $69.37 | 2024-11-15 | |
| 2024-11-15 | CARREL MICHAEL H Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $36.90 | 2024-11-15 | |
| 2024-11-15 | CARREL MICHAEL H Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $50.15 | 2024-11-15 | |
| 2024-07-24 | COHEN RAYMOND W Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −78,125 0 owned after | $25.82 exercise price | 2024-07-25 | |
| 2024-07-24 | COHEN RAYMOND W Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,771 196,451 owned after | $14.19 exercise price | 2024-07-25 |